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Abstract
Objective:  Dexmedetomidine  is  an  -2  adrenergic  agonist  having  wide  range  of  effects  including
sedation  in  mammalian  brain,  and  has  analgesic  as  well  as  sympatholytic  properties.  This  study
aimed to  compare  the  effects  of  dexmedetomidine  and  propofol  infusion  on  sedation  charac-
teristics in  patients  undergoing  combined  sciatic  nerve  and  femoral  nerve  block  via  anterior
approach  for  lower  limb  orthopedic  procedure.
Methods:  Forty  patients,  who  were  between  18  and  65  years  old,  this  study  was  made  at  anes-
thesiology  clinic  of  Bag˘cılar  training  and  research  hospital  in  08  September  2011  to  07  June
2012, and  underwent  surgical  procedure  due  to  fractures  lateral  and  medial  malleol,  were
included.  Sciatic  nerve  and  femoral  nerve  block  were  conducted  with  an  anterior  approach
on all  patients  included  in  the  study,  with  an  ultrasonography.  The  patients  were  randomly
divided into  dexmedetomidine  [Group  D  (n  =  20);  0.5  g  kg−1 h−1]  and  propofol  [Group  P  (n  =  20);
3 mg  kg−1 h--1]  infusion  groups.
Results:  The  vital  ﬁndings  and  intra-operative  Ramsay  sedation  scale  values  were  similar  in
both groups.  Time  taken  for  sedation  to  start  and  time  required  for  sedation  to  become  over
of Group  D  were  signiﬁcantly  higher  than  those  of  Group  P  (p  <  0.001  for  each).
Conclusions:  Substitution  of  dexmedetomidine  instead  of  propofol  prolongs  the  times  to  start
of sedation,  the  times  to  end  of  sedation  and  duration  of  sedation.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights
reserved.∗ Corresponding author.
E-mails: akyektas722000@yahoo.co.uk, akyektas@hotmail.com (A. Yektas¸).
0104-0014/$ – see front matter © 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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Características  da  sedac¸ão com  infusão  de  dexmedetomidina  e propofol  em  pacientes
submetidos  ao  bloqueio  do  nervo  ciático  em  combinac¸ão  com  bloqueio  do  nervo
femoral  via  abordagem  anterior
Resumo
Objetivo:  Dexmedetomidina  é  um  agonista  2-adrenérgico  que  tem  uma  ampla  gama  de  efeitos,
incluindo sedac¸ão  do  cérebro  de  mamíferos,  e  propriedades  tanto  analgésicas  quanto  simpa-
tolíticas.  Este  estudo  teve  como  objetivo  comparar  os  efeitos  de  dexmedetomidina  e  propofol
sobre as  características  da  sedac¸ão  em  pacientes  submetidos  ao  bloqueio  combinado  dos  nervos
ciático e  femoral  via  abordagem  anterior  em  procedimento  ortopédico  de  membro  inferior.
Métodos: Quarenta  pacientes,  entre  18  e  65  anos,  submetidos  a  procedimento  cirúrgico  por
causa de  fraturas  lateral  e  medial  do  maléolo,  foram  incluídos  neste  estudo,  conduzido  no
Departamento  de  Anestesiologia  do,  Bag˘cılar  Training  and  Research  Hospital  de  8  de  setembro
de 2011  a  7  de  junho  de  2012.  O  bloqueio  dos  nervos  ciático  e  femoral  foi  feito  via  abor-
dagem anterior  em  todos  os  pacientes  incluídos  no  estudo,  com  ultrassonograﬁa.  Os  pacientes
foram randomicamente  divididos  em  dois  grupos  para  as  infusões  de:  dexmedetomidina  (grupo
D [n  =  20];  0,5  g  kg−1 h−1)  e  propofol  (grupo  P  [n  =  20];  35  mg  kg−1 h--1).
Resultados:  Os  sinais  vitais  e  os  valores  da  escala  de  sedac¸ão  de  Ramsay  no  período  intraoper-
atório foram  semelhantes  em  ambos  os  grupos.  Os  tempos  de  início  e  término  da  sedac¸ão  no
grupo D  foram  signiﬁcativamente  maiores  do  que  os  no  grupo  P  (p  <  0,001,  respectivamente).
Conclusão:  O  uso  de  dexmedetomidina  em  vez  de  propofol  prolonga  os  tempos  de  início,  tér-
mino e  durac¸ão  da  sedac¸ão.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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Antroduction
nxiety  may  lead  to  hypertension,  arrhythmia  and  increase
n  myocardial  oxygen  consumption  by  causing  higher  sympa-
hetic  stimulation  in  patients  undergoing  surgical  procedure
nder  local  or  general  anesthesia.  Generally,  sedation  and
on-surgical  pain  management  during  a  surgery  in  patients
ndergoing  surgical  procedure  under  regional  anesthesia  has
ecome  an  important  issue  in  the  anesthesiology  practice.1
rimary  aim  of  the  sedation  includes  providing  comfort  to
atients,  eliminating  anxiety,  maintenance  of  hemodynamic
tability  and  restraining  patient  from  moving.  Dexmedeto-
idine  is  an  -2  adrenergic  agonist  which  is  more  selective
han  clonidine  and  has  wide  range  of  effects  including  seda-
ion  in  mammalian  brain  without  causing  anesthesia  as  well
s  has  analgesic  and  sympatholytic  properties.2 The  most
mportant  advantage  of  dexmedetomidine  is  lack  of  proper-
ies  that  may  cause  respiratory  depression,  although  it  may
auses  deep  sedation  at  therapeutic  doses.3 Owing  to  such
ovel  properties,  dexmedetomidine  may  be  a  safer  drug  to
rovide  sedation  in  patients  undergoing  peripheral  nerve
lock.  It  has  been  used  for  sedation  in  various  anesthesia
rocedure  like  MRI,  spinal  anesthesia  involving  vide  range
f  patients  including  infants  and  children.4 High  dose  of
exmedetomidine  has  been  successfully  used  in  pediatric
agnetic  resonance  imaging  (MRI)  sleep  studies.5 Addition-
lly,  in  a  case  report  it  was  reported  that  dexmedetomidine
as  successfully  and  safely  used  for  sedation  during  spinal
nesthesia  of  a  very  old  patient.6 Dexmedetomidine  has  also
een  used  effectively  for  the  sedation  of  infants  and  children
uring  spinal  anesthesia  in  combination  with  ketamine  pre-
erving  cardiovascular  and  respiratory  functions.7 Favorable
esults  have  been  obtained  by  dexmedetomidine  sedation
t
a
t
I˙uring  septoplasty  surgery  under  local  anesthesia  in  terms
f  satisfaction  from  anesthesia  and  surgery.8 However,  it  has
ot  been  used  for  sedation  in  various  other  regional  anes-
hesia  procedures  such  as  lower  limb  nerve  block.
Propofol  is  being  safely  and  successfully  used  for  a  long
ime  during  any  intervention  and  imaging  technique  requir-
ng  sedation  in  patients  with  spontaneous  respiration,  as
ell  as  in  regional  anesthesia  and  peripheral  nerve  blocks.
arious  studies  have  shown  that  propofol  is  a  preferable
gent  for  sedation  when  used  in  combination  with  opioids
ince  its  efﬁcacy  starts  and  ends  easily  and  dose  titration
s  easily  performed.9,10 Bilateral  brachial  plexus  block  has
een  successfully  performed  with  propofol--ketamine  seda-
ion  under  ultrasonography  guidance.11
Sciatic  nerve  block  via  anterior  approach  can  be
erformed  under  ultrasonography  guidance  and  such  an
pproach  is  very  comfortable  for  the  patient;  femoral  nerve
lock  as  well  can  be  performed  at  the  same  time  in  the  same
egion.12,13
The  present  study  was  aimed  to  compare  the  effects  of
ntravenous  continuous  infusion  of  dexmedetomidine  and
ropofol  on  the  sedation  characteristics  of  patients  under-
oing  sciatic  nerve  block  and  femoral  nerve  blocks  through
nterior  approach.
aterials and methods
fter  the  study  was  approved  by  the  local  ethics  commit-
ee  of  Yeditepe  University  Medical  Faculty  (approval  date
nd  number:  02.08.2011;  130),  this  study  was  made  at  anes-
hesiology  clinic  of  Bag˘cılar  training  and  research  hospital,
stanbul,  Turkey  in  08  September  2011  to  07  June  2012,
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40  patients,  who  were  between  18  and  65  years  old,  in
the  American  Society  of  Anesthesiologists  (ASA)  classiﬁca-
tion  I--II,14 and  had  undergone  surgical  procedure  due  to
lateral  and  medial  malleol  fractures,  were  included  in  the
study  after  the  approval  of  local  ethics  committee  and  writ-
ten  informed  patient  consent  were  obtained.  This  study
has  been  prepared  in  accordance  with  the  principles  of  the
Helsinki  declaration.
Age,  gender,  height  and  weight  of  the  patients,  as  well
as  concomitant  diseases,  history  for  drug  use  and  smok-
ing,  anesthesia  technique,  surgery  duration,  tourniquet
duration,  ASA  classiﬁcation,  systolic  and  diastolic  blood
pressures,  peripheral  oxygen  saturation,  heart  rate,  onset  of
sedation,  level  of  sedation,  time  of  termination  of  sedation,
were  recorded.
Inclusion  criteria:
1.  Patients  of  between  18  and  65  years  old.
2.  Patients  with  ASA  I--II.
3.  Patients  with  lateral  and  medial  malleol  fractures.
Exclusion  criteria:
1.  Patients  with  vascular  disease,  cardiac  disease  [I--II
degree  atrioventricular  (AV)  block].
2.  Metabolic-renal-hepatic  disease.
3.  Pregnancy.
4.  Hemodynamic  instability.
5.  Drug  use  that  is  likely  to  cause  metabolic  acid--base
imbalance.
6.  History  for  steroid  use  and  allergy.
7.  Contraindications  to  regional  anesthesia.
8.  Alcohol  --  drug  addiction.
9.  Those  who  did  not  graduate  from  primary  school  were
excluded  from  the  study.
The  Ramsay  sedation  scale15 (RSS)  was  used  to  assess  the
level  of  sedation.  The  modiﬁed  Aldrete  scoring  system16 was
used  to  assess  recovery  from  anesthesia.  The  patients  having
no  premed  were  divided  into  two  groups  [Group  dexmedeto-
midine  (D;  n  =  20)  and  Group  propofol  (P;  n  =  20)]  on  the
day  of  surgery  according  to  the  computerized  randomiza-
tion  scheme.17 Electrocardiography,  non-invasive  arterial
blood  pressure  measurement  and  peripheral  pulse  oxime-
try  were  performed  after  the  patients  were  admitted  into
the  surgery  room  and  basal  values  of  their  vital  signs  were
recorded.  For  sedation,  Group  D  received  dexmedetomi-
dine  (Precedex,  Abbott,  Rock  Mount,  NC,  USA)  infusion  at
a  dose  of  1  g  kg−1 for  the  ﬁrst  10  min  and  0.5  g  kg−1 h−1
throughout  the  surgery.  Patients  in  Group  P  received  2%
propofol  (Propofol-®Lipuro,  B.  Braun,  Melsungen  AG,  Ger-
many)  at  a  dose  of  1  mg  kg−1 as  the  loading  dose  (in  a
minute)  prior  to  the  block  and  then  infusion  was  started  at
a  rate  of  3  mg  kg−1 h−1 and  continued  at  the  end  of  surgery.
Both  groups  simultaneously  received  0.9%  NaCl  at  a  rate  of
10  mL  kg−1 h−1 for  the  ﬁrst  hour  and  continued  at  a  rate  of
5  mL  kg−1 h−1.  Vital  signs  were  measured  at  5  min  intervals
after  dexmedetomidine  or  propofol  infusion  was  started,
and  the  time  to  start  sedation  (RSS  score  between  2  and  4)
was  recorded.  Sciatic  nerve  block  and  femoral  nerve  block
were  performed  10  min  after  dexmedetomidine  infusion  and
5  min  after  propofol  infusion  via  anterior  approach  using
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timuplex® A  (21  G  0.80--150  mm)  block  needles  (B.  Braun,
elsungen  AG,  Germany),  of  which  the  isolated  tip  was
0◦,  under  ultrasonography  (Diagnostic  ultrasound  system,
odel  SDU  450  XL  Class-1  type  B,  Shimadzu  Corporation,
okohama,  Japan)  guidance  together  with  nerve  stimulator
Stimuplex  HNS  nerve  stimulator,  Braun,  Melsungen,  Ger-
any).  A  total  of  40  mL  anesthetic  solution  including  30  mL
f  0.5%  isobaric  bupivacaine  and  10  mL  of  2%  lidocaine  was
repared.  The  nerves  were  stimulated  by  a  stimulus  with
 Hz  frequency  and  1 mA  ﬂow;  stimulus  intensity  was  gradu-
lly  decreased  to  0.4  mA.
In  femoral  nerve  block,18 contractions  of  vastus  medi-
lis,  vastus  intermedialis  and  vastus  lateralis  were  observed
ndividually  and  the  dispersion  of  local  anesthetic  was
emonstrated  by  ultrasonography  (linear  probe)  during  the
nfusion  of  20  mL  of  local  anesthetic  mixture.  In  sciatic  nerve
lock,19 when  the  plantar  ﬂexion,  dorsiﬂexion  and  eversion
f  the  foot  were  seen,  the  dispersion  of  local  anesthetic  was
emonstrated  by  ultrasonography  (convex  probe)  during  the
nfusion  of  20  mL  of  local  anesthetic  mixture.
After  the  block  was  performed  in  both  groups,  the  block
as  evaluated  by  cold  compress  with  ice  battery;  time  to
tart  sensory  block  was  recorded.  On  the  30th  min  after  the
lock,  the  patients  were  transferred  for  the  surgery  and  RSS
cores  were  recorded  every  5  min.  All  patients  were  followed
p  by  the  same  anesthesiologist.
Dexmedetomidine  and  propofol  infusion  rates  were  ﬁxed
n  both  groups,  when  needed,  to  ﬁx  the  sedation  levels
etween  2  and  4  according  to  the  RSS.
Dexmedetomidine  and  propofol  infusions  were  discontin-
ed  at  the  end  of  surgery  and  the  patients  were  transferred
o  the  postoperative  care  unit.  The  patients,  then,  trans-
erred  to  the  clinic  when  their  modiﬁed  Aldrete  scores  were
9.
tatistical  analysis
he  10-case  pre-study  that  we  conducted  showed  that  the
ean  artery  pressure  in  the  dexmedetomidine  group  was
2  ±  5  mm  Hg  and  76  ±  5  mm  Hg  in  the  propofol  group;  as
he  mean  artery  pressure  difference  is  6  mm  Hg  and  the
tandard  effect  size  is  1.2  with  95%  power  and  5%  falli-
ility,  n  =  20  for  each  group.  All  data  for  the  study  was
valuated  with  the  SPSS  package  program  for  Windows
1.05.  All  data  were  expressed  as  mean  ±  standard  devia-
ion.  The  normality  analysis  of  the  data  was  conducted  with
he  Kolmogorov--Simirnov  test.  The  study  groups  were  also
ompared  by  chi-square  test  with  respect  to  age,  height,
ody  weight,  gender,  ASA  classiﬁcation.  The  study  groups
ere  compared  by  independent  sample  t  test  in  terms  of
rterial  blood  pressure,  heart  rate  and  peripheral  oxygen
aturation  used.  The  study  groups  were  also  compared  using
he  Mann--Whitney  U  test  with  Bonferroni  correction  with
espect  to  sedation  levels  during  surgery  according  to  RSS,
nd  time  to  start  and  end  sedation.  A  p  value  <0.05  was
onsidered  statistically  signiﬁcant.esults
ge  (p  =  0.901),  height  (p  =  0.852),  body  weight  (p  =  0.112),
ender  (p  =  0.714),  ASA  classiﬁcation  (p  =  1000),  surgery
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Table  1  Distribution  of  general  characteristics  of  the  study  groups.
Group  D  Group  P  p
Age  (year)  38.05  ±  12.03  38.55  ±  12.30  0.901
Height (mm)  169.95  ±  10.22  170.50  ±  8.20  0.852
Body weight  (kg)  72.55  ±  16.65  79.80  ±  10.77  0.112
Gender (male/female)  15/5  16/4  0.714
ASA (ASA  I/ASA  II)  15/5  17/3  1.000
Surgery duration  (min)  80.75  ±  26.27  89.80  ±  33.81  0.351
Tourniquet time  (min)  67.55  ±  22.88  69.22  ±  27.33  0.654
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tD, dexmedetomidine; P, propofol.
Data are expressed as mean ± standard deviation or number wher
uration  (p  =  0.351)  and  Tourniquet  time  (p  =  0.654)  of  the
atients  are  presented  in  Table  1.  There  were  no  signiﬁcant
ifferences  between  Group  D  and  Group  P  in  terms  of  these
ata.
There  were  no  signiﬁcant  differences  between  the
roups  in  terms  of  arterial  blood  pressure,  heart  rate,  and
eripheral  oxygen  saturation  measured  every  5  min  after
exmedetomidine  or  propofol  infusion  was  started.  Blood
ressure  values  of  the  patients  are  presented  in  Table  2
nd  heart  rate  and  peripheral  oxygen  saturation  values  are
resented  in  Table  3.
t
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Table  2  Comparison  of  intraoperative  blood  pressure  values  betw
Blood  pressure  (mm  Hg)  Group  D  
Basal
Systolic  128.70  ±  16.46  
Diastolic 73.85  ±  11.88  
5th min  of  the  infusion
Systolic  114.40  ±  30.97  
Diastolic 70.05  ±  14.94  
5th min  after  peripheral  nerve  block
Systolic  114.45  ±  9.38  
Diastolic 70.00  ±  10.55  
15th min  after  peripheral  nerve  block
Systolic  124.55  ±  15.77  
Diastolic 75.05  ±  13.29  
5th min  of  the  surgery
Systolic  122.95  ±  13.96  
Diastolic 74.50  ±  13.56  
10th min  of  the  surgery
Systolic  126.15  ±  15.07  
Diastolic 79.85  ±  13.39  
20th min  of  the  surgery
Systolic  126.40  ±  16.06  
Diastolic 78.95  ±  10.74  
30th min  of  the  surgery
Systolic  129.40  ±  14.95  
Diastolic 79.15  ±  14.25  
D, dexmedetomidine; P, propofol.
Data are expressed as mean ± standard deviation.ropriate.
RSS  scores  measured  every  5  min  after  the  start  of  surgery
re  presented  in  Table  4.  There  was  no  signiﬁcant  differ-
nce  between  the  groups  in  terms  of  intraoperative  RSS
cores.
Mean  time  to  start  sedation  (RSS  scores  between  2  and
)  after  the  start  of  dexmedetomidine  or  propofol  infusion
as  found  to  be  signiﬁcantly  longer  in  Group  D  as  compared
o  that  in  Group  P  (8.10  ±  1.07  and  3.80  ±  0.83,  respec-
ively;  p  <  0.001).  Time  to  recovery  from  sedation  following
iscontinuation  of  dexmedetomidine  or  propofol  infusion
modiﬁed  Aldrete  sedation  scale  score  = 9)  was  signiﬁcantly
een  the  study  groups.
Group  P  p
133.05  ±  14.88  0.386
74.90  ±  12.44  0.786
122.80  ±  21.20  0.324
71.35  ±  11.05  0.756
119.10  ±  16.68  0.284
68.35  ±  9.90  0.613
121.00  ±  17.18  0.50
71.45  ±  12.52  0.383
123.50  ±  15.97  0.908
74.25  ±  10.09  0.948
126.85  ±  15.80  0.887
76.55  ±  13.79  0.447
126.95  ±  32.11  0.946
78.25  ±  16.13  0.823
131.75  ±  13.70  0.607
78.10  ±  12.13  0.803
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Table  3  Comparison  of  the  study  groups  in  terms  of  heart  rate  and  peripheral  oxygen  saturation.
Group  D  Group  P  p
Heart  rate  (beat  min−1)
Basal  83.90  ±  18.47  83.40  ±  11.77  0.919
5th min  of  the  infusion  76.25  ±  19.25  78.35  ±  12.72  0.686
5th min  after  peripheral  nerve  block  69.20  ±  16.91  76.80  ±  11.50  0.105
5th min  of  the  surgery  65.95  ±  13.98  75.45  ±  11.89  0.056
10th min  of  the  surgery  66.45  ±  13.11  71.15  ±  11.73  0.239
20th min  of  the  surgery 64.45  ±  11.78 71.25  ±  11.79 0.076
30th min  of  the  surgery 70.40  ±  13.52 76.30  ±  13.66 0.178
Peripheral  oxygen  saturation  (%)
Basal  98.35  ±  1.27  97.90  ±  2.49  0.476
5th min  of  the  infusion  98.35  ±  1.84  98.90  ±  2.36  0.417
5th min  after  peripheral  nerve  block 98.85  ±  1.57  99.22  ±  1.82  0.519
5th min  of  the  surgery 99.25  ±  0.91  99.20  ±  2.50  0.934
10th min  of  the  surgery 99.25  ±  1.02  98.90  ±  3.37  0.659
20th min  of  the  surgery 99.35  ±  0.81 99.80  ±  3.37  0.482
30th min  of  the  surgery 99.25  ±  0.85 98.80  ±  3.78 0.606
D, dexmedetomidine; P, propofol.
Data are expressed as mean ± standard deviation.
Table  4  Comparison  of  the  groups  in  terms  of  intraoperative  Ramsay  sedation  scale  scores.
Group  D  Group  P  p
Ramsay  sedation  scale  scores
5th  min  of  the  surgery  2.80  ±  1.28  2.85  ±  1.42  0.912
10th min  of  the  surgery  3.15  ±  1.27  3.15  ±  1.14  0.966
20th min  of  the  surgery  3.15  ±  1.23  3.15  ±  1.09  0.978
30th min  of  the  surgery  3.30  ±  0.92  3.50  ±  0.94  0.495
2
i
DD, dexmedetomidine; P, propofol.
Data are expressed as mean ± standard deviation.
longer  in  Group  D  than  that  in  Group  P  (22.30  ±  3.32  min  and
9.90  ±  2.10  min,  respectively,  Tables  5  and  6;  p  <  0.001).
With  regard  to  adverse  events,  one  patient  in  Group
D  developed  bradycardia  (<60  rate  min−1)  and  was  treated
with  0.5  mg  atropine  intravenously.
Twelve  patients  were  excluded  because  of  inadequate
block  (9  sciatic  and  3  sciatic  +  femoral).
In  Group  D,  one  patient  did  not  even  reach  the  RSS  level
of  2  with  0.5  g  kg−1 h−1 dose  of  dexmedetomidine  whereas
B
a
a
a
Table  5  The  time  it  took  for  the  Ramsay  sedation  scale  points  t
propofol infusion  was  initiated  in  the  groups.
Time  passed  for  the  Ramsay  sedation  scale  points  to  achieve
the range  2--4  (min)
D, dexmedetomidine; P, propofol.
Data are expressed as mean ± standard deviation.
* When Group D and Group P are compared in terms of their Ramsay s
of dexmedetomidine and propofol was initiated, this period was longer 
differenced present between Group D and Group P, <0.001. patients  reached  the  level  of  RSS  5--6;  however,  4  patients
n  the  Group  P  had  an  RSS  level  of  5--6.
iscussionenzodiazepines,  propofol,  -2  adrenoceptor  agonists  such
s  clonidine  and  dexmedetomidine,  sevoﬂurane,  ketamine
nd  opioids  are  used  to  reduce  procedure-associated  fear
nd  anxiety  to  enhance  comfort  to  patient.20 Although
o  achieve  the  range  of  2--4  after  the  dexmedetomidine  and
Group  D  Group  P  p
8.10  ±  1.07  3.80  ±  0.83 *<0.001
edation scale points achieving the range of 2--4 after the infusion
in Group D than in Group P and there were statistically signiﬁcant
376  A.  Yektas¸  et  al.
Table  6  The  time  it  took  for  the  modiﬁed  Aldrete  sedation  scale  points  to  achieve  9  after  the  dexmedetomidine  and  propofol
infusion was  suspended.
Group  D  Group  P  p
Time  passed  for  the  modiﬁed  Aldrete  sedation  scale  points  to
achieve 9  (min)
22.30  ±  3.32  9.90  ±  2.10 *<0.001
D, dexmedetomidine; P, propofol.
Data are expressed as mean ± standard deviation.
* When Group D and Group P are compared in terms of their modiﬁed Aldrete sedation scale points achieving 9 after the infusion of
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adexmedetomidine and propofol was suspended, this period was lo
differenced present between Group D and Group P, <0.001.
exmedetomidine  is  being  used  in  intensive  care  units  for
 long  time  for  sedation,  there  is  limited  information  about
ts  use  for  intraoperative  sedation.4 In  the  present  study,  we
imed  to  evaluate  whether  dexmedetomidine  can  be  used
or  sedation  during  peripheral  nerve  block  and  to  investigate
he  effects  of  dexmedetomidine  on  sedation  characteristics
n  comparison  to  propofol.
Dexmedetomidine  is  an  -2  receptor  agonist.  Studies
ave  shown  that  -2  receptor  agonists  have  analgesic,
edative--hypnotic  and  sympatholytic  properties.21,22 There
re  studies  suggesting  that  dexmedetomidine  is  an  effective
rug  in  intraoperative  sedation.23,24 Shehabi  et  al.25 per-
ormed  dexmedetomidine  infusion  (0.2--0.7  g  kg−1 h−1) for
n  average  of  71.5  h  for  sedation  of  60  critical  patients  in
he  intensive  care  unit  with  a  ﬁxed  dose  infusion  to  achieve
core  between  2  and  4.  They  ﬁxed  the  infusion  dose  that
SS  score  would  be  between  2  and  4.  They  concluded  that
exmedetomidine  can  be  used  for  an  effective  sedation
nd  as  a  substitute  analgesic  in  critical  patients  without
ausing  signiﬁcant  changes  in  vital  signs  within  24  h  period.
n  the  present  study,  we  used  dexmedetomidine  for  seda-
ion  during  anterior  sciatic  nerve  block  in  combination  with
emoral  nerve  block.  We  ﬁxed  the  dexmedetomidine  infu-
ion  dose  to  be  0.5  g  kg−1 h−1 and  applied  a  loading  dose  of
 g  kg−1 for  10  min  prior  to  the  infusion;  thus,  In  our  study,
 out  of  23  patients  had  reached  the  level  of  RSS  5--6  with
.5  g  kg−1 h−1 dose  of  dexmedetomidine;  however,  these
atients  did  not  develop  respiratory  depression  and  their
ital  ﬁndings  were  within  physiological  limits.  No  signiﬁcant
hange  was  observed  in  the  vital  signs  of  the  patients  in
roup  D  and  vital  signs  were  also  similar  to  that  of  Group  P.
Intravenous  use  of  sedative  and  hypnotic  drugs  dur-
ng  regional  anesthesia  as  supportive  medication  enhances
atient  comfort26,27 with  minimum  morbidity  and  mortality
nd  maintains  cardiovascular  stability  by  lowering  periop-
rative  stress.28 In  the  present  study,  we  aimed  to  enhance
atient  comfort  with  dexmedetomidine  and  propofol  infu-
ion  and  observed  that  the  similar  sedation  had  been
chieved  in  Group  D  as  compared  to  that  in  Group  P.
An  ideal  sedation  during  regional  anesthesia  requires
n  open  airway,  a  reliable  sleep  state,  minimally  inﬂu-
nced  cardiovascular  system,  and  a  rapid  recovery  period
rom  anesthesia.1 MRI  sleep  studies  conducted  on  the  chil-
ren  with  obstructive  sleep  apnea  have  demonstrated  that
exmedetomidine  requires  low  rate  of  airway  intervention
s  compared  to  propofol.  Although  dexmedetomidine  has
aused  signiﬁcant  decrease  in  heart  rate  and  propofol  has
aused  signiﬁcant  decrease  in  arterial  blood  pressure,  the
o
c
s
cin Group D than in Group P and there were statistically signiﬁcant
rocedure  has  not  been  discontinued  and  MRI  sleep  study  has
een  completed  successfully.29 In  the  present  study,  none  of
he  patients  required  airway  support  and  no  signiﬁcant  dif-
erence  was  observed  between  the  groups  in  terms  of  vital
igns.  However,  time  to  recovery  from  anesthesia  was  found
igniﬁcantly  longer  in  Group  D  as  compared  to  Group  P.
Intraoperative  sedation  during  regional  anesthesia
nhances  the  quality  of  local  and  regional  anesthesia  by
roviding  optimum  patient  comfort  with  minimum  morbid-
ty  and  mortality.  Nevertheless,  it  is  very  difﬁcult  to  provide
dequate  level  of  sedation  due  to  the  variabilities  in  the
atient  expectations  regarding  sedation  level,  differences
n  intraoperative  conditions,  and  pharmacokinetic  and  phar-
acodynamic  properties  of  the  agents.  In  the  present  study,
e  tried  to  preserve  the  adequate  level  of  sedation  by  suc-
essful  adjustment  of  infusion  rates  of  dexmedetomidine
nd  propofol.  The  RSS  scores  of  the  patients  were  found
o  be  similar  in  both  study  groups.
It  is  stated  that  dexmedetomidine  is  frequently  used  for
edation  in  intensive  care  units  and  that  it  is  an  agent  with
hich  patient  cooperation  is  better  as  compared  to  other
rugs.30,31 In  the  present  study,  the  level  of  sedation  was
ept  between  2  and  4  according  to  RSS  and  no  signiﬁcant
ifference  was  obtained  between  the  study  groups  in  terms
f  sedation  at  that  level;  thus,  the  cooperation  levels  of  the
tudy  groups  were  found  to  be  similar.
Dexmedetomidine  provides  dose-dependent  sedation  and
rolongs  the  sensorial  block.  However,  it  has  been  stated
hat  dexmedetomidine  may  cause  unintended  hemodynamic
mpairment,  and  nausea  and  vomiting.31 Neither  nausea,
omiting  nor  unintended  hemodynamic  impairment  was
bserved  in  the  present  study.
Intravenous  -2  adrenoceptor  agonist  administration
auses  a  decrease  in  heart  rate,  and  temporary  increase
n  arterial  blood  pressure  and  systemic  vascular  resistance
ue  to  the  activation  of  postjunctional  vascular  -2  adreno-
eptors.  Subsequently,  long-term  decrease  in  heart  rate  and
lood  pressure  is  observed  due  to  the  decrease  in  central
ympathetic  tonus  and  vagal  activity.4,31 Dexmedetomidine
rovides  a  predictable  stable  hemodynamics  when  admin-
stered  as  continuous  infusion.  In  the  present  study,  blood
ressure  and  heart  rate  values  were  found  similar  in  both
tudy  groups.  In  Group  D,  one  patient  developed  bradycardia
nd  was  treated  with  0.5  mg  atropine  intravenously.  More-
ver,  patients  with  hypovolemia,  vasoconstriction  or  severe
ardiac  block  had  already  been  excluded  from  the  study
ince  they  were  likely  to  develop  hypotension  and  brady-
ardia.
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1Dexmedetomidine  and  propofol  
The  most  important  advantage  of  dexmedetomidine  is
that  it  dose  not  cause  respiratory  depression,  although  it
may  cause  deep  sedation  at  therapeutic  doses.3,32,33 In  our
study,  2  out  of  23  patients  in  Group  D  had  reached  the
level  of  RSS  5--6  with  0.5  g  kg−1 h−1 dose  of  dexmedeto-
midine;  however,  these  patients  did  not  develop  respiratory
depression  and  their  vital  ﬁndings  were  within  physiological
limits.
There  are  similar  studies,  which  used  dexmedetomi-
dine  for  intraoperative  sedation  in  awake  patients.24,25
Arain  et  al.17 compared  dexmedetomidine  and  propofol
during  intraoperative  sedation  and  found  no  difference  in
psychomotor  performance  and  respiratory  rate  during  recov-
ery.  They  also  found  that  later  onset  and  termination  of
sedation  was  observed  in  the  dexmedetomidine  group  as
compared  to  the  propofol  group,  whereas  postoperative
analgesia  was  better  and  analgesic  consumption  was  lower
in  the  dexmedetomidine  group.  In  the  present  our  study,
the  effects  of  dexmedetomidine  and  propofol  on  the  post-
operative  analgesic  characteristic  of  sciatic--femoral  block
were  found  similar  since  half-lives  of  dexmedetomidine  and
propofol  was  shorter  than  action  time  of  sciatic--femoral
block.  However,  consistent  with  the  above-mentioned  study,
later  onset  and  termination  of  sedation  was  observed  in
dexmedetomidine  group  than  propofol  group  in  the  present
study.
Limitation
The  result  of  the  primary  measurement  of  this  study  is
the  RSS  values  after  dexmedetomidine  and  propofol  seda-
tion.  Future  studies  that  show  that  dexmedetomidine  can
be  used  for  sedation  during  the  intra-operative  period  and
that  present  the  effects  of  dexmedetomidine  on  the  char-
acteristics  of  the  sciatic--femoral  block  with  an  anterior
approach  should  be  encouraged.  The  RSS  used  to  identify
the  degree  of  sedation  is  subjective;  it  is  limited  due  to
the  patient  providing  verbal  evaluations.  RSS  is  a  subjective
measurement;  however,  it  has  been  described  previously.15
RSS  does  not  provide  objective  data  regarding  the  sedation
status  of  the  patient.  RSS  values  depend  on  the  particular
pharmaco-dynamic  and  pharmaco-kinetic  characteristics  of
the  sedative  drug  on  different  people.34 The  patients’  vital
ﬁndings  were  evaluated  and  their  compatibility  with  the
RSS  values  were  compared.  Verbal  dialogs  were  continued
with  the  patient  in  order  to  perform  a  correct  and  accu-
rate  sedation  evaluation.  The  patients  were  informed  on  RSS
before  the  operation.  The  RSS  inquiry  was  performed  on  all
patients  by  the  same  anesthetist.  Future  studies  will  study
using  objective  methods  to  identify  the  degree  of  sedation
while  intra-operatively  using  dexmedetomidine.
Conclusion
In  conclusion,  it  was  observed  that  sedation  could  be
achieved  in  the  range  of  RSS  2--4  via  dexmedetomidine
at  a  dose  of  0.5  g  kg−1 h−1 or  propofol  infusion  at  a
dose  of  3  mg  kg−1 h−1 administered  for  sedation  purposes
on  patients  undergoing  sciatic--femoral  nerve  block  with
an  anterior  approach.  It  was  considered  that  dexmedeto-
midine  had  propofol-like  effects  on  patients  undergoing
1377
 sciatic--femoral  nerve  block  with  an  anterior  approach
nd  that  it  could  be  used  in  place  of  propofol.  However,
t  was  observed  that  some  patients  could  have  RSS  lev-
ls  of  5--6  via  the  infusion  of  dexmedetomidine  at  a  dose
f  0.5  g  kg−1 h−1 or  propofol  at  a  dose  of  3  mg  kg−1 h−1.
imilarly,  it  was  observed  that  some  patients  could  expe-
ience  inadequate  sedation  via  dexmedetomidine  infusion.
t  was  observed  that  the  time  between  sedation  onset  and
nding  with  dexmedetomidine  at  a  dose  of  0.5  g  kg−1 h−1
as  longer  than  sedation  time  induced  via  propofol  at  a
ose  of  3  mg  kg−1 h−1 at  a statistically  signiﬁcant  level  for
atients  undergoing  sciatic--femoral  nerve  block  with  an
nterior  approach.
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